体检十年未查出癌症？爱康国宾最新回应：已诉讼并获法院立案

Core Viewpoint - The controversy surrounding Aikang Guobin involves allegations of "fake health check-ups" after a lawyer, Zhang Xiaoling, was diagnosed with cancer despite years of normal test results from the company [1][2]. Group 1: Allegations and Responses - Zhang Xiaoling claims that Aikang Guobin's health checks failed to detect her cancer risk over a decade, leading to a late-stage diagnosis [1][2]. - Aikang Guobin has conducted internal and external evaluations, asserting that there were no misdiagnoses or false checks, and has initiated legal action against Zhang for defamation [2][6]. - The company emphasizes that health checks are not equivalent to medical diagnoses and are intended to identify potential health issues for further investigation by specialists [3]. Group 2: Medical Insights and Procedures - Aikang Guobin's medical professionals clarified that the 2023 ultrasound report indicated potential issues that warranted further examination, contradicting Zhang's claims [3][5]. - The company highlighted that cancer markers like carcinoembryonic antigen (CEA) are not reliable for early detection of kidney cancer, as imaging techniques are the primary diagnostic tools [5]. - Aikang Guobin maintains that it follows industry standards regarding the retention of blood samples, which typically last only 1-7 days, making it impossible to keep samples from the past decade [4]. Group 3: Impact on the Industry - The allegations have raised concerns about public trust in private health check-up centers and the broader healthcare industry in China, affecting the reputation of Aikang Guobin and its employees [6]. - The company asserts that the claims have harmed its reputation and the trust of its approximately 8 million annual clients [6].